Ultragenyx Pharmaceutical (RARE) has earned its first FDA approval in gene therapy, landing an accelerated green light for its treatment targeting glycogen storage disease type Ia. The FDA approved pariglasgene brecaparvovec-opnr, previously
City analysts are forecasting further gains for Marks and Spencer Group shares, which have already outpaced the broader market by a significant margin in 2026. Marks and Spencer (LSE: MKS) shares are
More
The FTSE 100 found support from utility stocks during an edgy trading session, as investors sought refuge in defensive sectors amid broader market uncertainty. Utility companies, traditionally seen as safe-haven investments during
More
Gilead Sciences Canada has taken home a Bronze Lion at Cannes for its creative HIV prevention campaign built around LGBTQIA+ community identity. The campaign, titled Animal Attraction, was developed in partnership with
More
U.S. Citizenship and Immigration Services announced on July 17, 2026, that it had received sufficient petitions to meet the congressionally mandated H-1B visa cap for fiscal year 2027. The announcement confirms that
More
Voice search is emerging as a critical front in legal digital marketing, yet many law firms remain focused elsewhere while potential clients slip away. Annette Choti, Esq., founder and CEO of Law
More
London’s FTSE 100 closed higher on Friday, bucking a broader global trend as technology sector weakness and geopolitical uncertainty weighed on markets elsewhere. The FTSE 100 Index ended the session up 28.13
More
The FTSE 100 index rose on Thursday, buoyed by strong gains across the utilities and energy sectors, lifting the broader market higher. Energy stocks provided meaningful upward momentum, reflecting continued investor appetite
More
CG Life and its 24/364 platform have officially launched the inaugural 24/364 Rare Disease Film Festival, a first-of-its-kind cultural event dedicated to rare disease storytelling. The festival aims to amplify the voices
More
As the 2026 election cycle advances, state attorney general races are emerging as a critical factor in how companies assess their legal and regulatory exposure across the country. Once considered niche political
More
The Department of Justice is drawing renewed criticism over its Biglaw subpoena strategy, with observers widely sceptical the approach will achieve its intended outcome. Legal commentators have suggested the DOJ’s handling of
More